Mark G. Foletta
Director at DexCom; Director at AMN Healthcare Services. Based in San Diego, California.
- Rank
- 6640th of 14,452
- Companies held
- 2
- Largest holding
- DXCM, 90.6% of total
- Latest SEC filing
- Aug 3, 2026
What the $14.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| DexCom DXCM Common Stock | Indirectly (see filing footnote) | 56,852 | $80.19 | $4.6M | 31.5% | Form 4, May 8, 2026 |
| DexCom DXCM Common Stock | Through Trust | 51,316 | $80.19 | $4.1M | 28.5% | Form 4, Aug 15, 2025 |
| DexCom DXCM Common Stock | Through Trust | 48,852 | $80.19 | $3.9M | 27.1% | Form 4, Aug 3, 2026 |
| AMN Healthcare Services AMN Common Stock | Directly | 21,598 | $34.35 | $742K | 5.1% | Form 4, May 1, 2026 |
| AMN Healthcare Services AMN Common Stock | Through Trust | 17,917 | $34.35 | $615K | 4.3% | Form 4, Jun 15, 2026 |
| DexCom DXCM Common Stock | Directly | 6,331 | $80.19 | $508K | 3.5% | Form 4, Jul 31, 2026 |
Share counts are the amounts Mark G. Foletta reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6637 | Peter Z. E. Vanacker Chief Executive Officer, LyondellBasell Industries | $14.5M |
| 6638 | Matthew K. Fawcett EVP, GC & Secretary, NetApp. Ashburn, VA | $14.5M |
| 6639 | Huntley Garriott President, Live Oak Bank, Live Oak Bancshares. Wilmington, NC | $14.5M |
| 6640 | Mark G. Foletta Director, DexCom. San Diego, CA | $14.5M |
| 6641 | Duston Williams Chief Financial Officer, Nutanix. San Jose, CA | $14.5M |
| 6642 | Richard E. Perlman Director, Onterris. North Little Rock, AR | $14.4M |
| 6643 | Robert I. Blum President & CEO, Cytokinetics. South San Francisco, CA | $14.4M |
Other DexCom insiders
All DXCM insiders- Eric Topol$60.8MDirector. #2211 overall
- Jacob Steven Leach$37.3MPresident, CEO, and Director. #3171 overall
- Kevin R. Sayer$24.2MExecutive Chair. #4483 overall
- Donald Abbey$16.7MEVP Global Business Services I. #5676 overall
- Jereme M. Sylvain$11.7MEVP, COO & CFO. #7831 overall
- Steven Robert Pacelli$10.0MEVP Managing Director Dexcom V. #8781 overall
Questions
How much stock does Mark G. Foletta own?
Mark G. Foletta holds $14,456,457 in listed stock based on SEC filings and current prices, mostly DexCom (DXCM). That ranks 6640th on the Stock Rich List.
Is this Mark G. Foletta's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mark G. Foletta last buy or sell stock?
The most recent open-market trade on file is a sale of 2,000 DXCM shares on Aug 3, 2026 at $85.32.